Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia

Psychiatry Research

Volumn 42, Issue 3, 1992, Pages 273-282

  Simpson, Michael D C ^a   Slater, Paul ^a   Royston, M Claire ^a   Deakin, J F William ^a  

^a Michael DC Simpson PhD Paul Slater PhD and M Claire Royston MRCPsych are from the Department of Physiological Sciences University of Manchester UK ^*

Author keywords

ligand binding; Post morterm study

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; GLUTAMIC ACID; NIPECOTIC ACID; SODIUM;

ADULT; AGED; ARTICLE; AUTOPSY; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ASPARTIC ACID; BRAIN; CAUDATE NUCLEUS; DOMINANCE, CEREBRAL; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; GLUTAMATES; GLUTAMIC ACID; HUMAN; NIPECOTIC ACIDS; NUCLEUS ACCUMBENS; PUTAMEN; RADIOLIGAND ASSAY; RECEPTORS, GABA-A; RECEPTORS, GLUTAMATE; RECEPTORS, NEUROTRANSMITTER; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUPPORT, NON-U.S. GOV'T;

EID: 0026648135     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(92)90119-N     Document Type: Article

References (42)

1. The functional anatomy of basal ganglia disorders: A review
2. Parallel organisation of functionally segregated circuits linking basal ganglia and cortex
3. Basal ganglia and limbic system pathology in schizophrenia: A morphometric study of brain volume and shrinkage
4. Post-mortem evidence of structural brain changes in schizophrenia: Differences in brain weight, temporal horn area and parahippocampal gyrus compared with affective disorder
5. Cerebral glucography with positron tomography: Use in normal subjects and patients with schizophrenia
6. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schiz ophrenic patients
7. Chronic haloperidol treatment up-regulates rat brain PCP receptors
8. Interactions between glutamatergic and monoaminergic systems within the basal ganglia—Implications for schizophrenia and Parkinson's disease
9. Chemical and structural changes in the brain in patients with movement disorder
10. Gamma-aminobutyric acid in the brain in schizophrenia
11. 3H]-aspartate binding and high-affinity glutamate uptake in the human brain
12. Lowry method of protein quantification: Evidence for photosensitivity
13. Frontal cortical and left glutamatergic dysfunction in schizophrenia
14. Positron emission tomography in schizophrenic patients with and without neuroleptic medication
15. Left globus pallidus abnormality in never-medicated patients with schizophrenia
16. Commentary and synthesis
17. Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls
18. Sodium-dependent D-aspartate “binding” is not a measure of presynaptic neuronal uptake sites in an autoradiographic assay
19. Regional brain function in schizophrenia: I. A positron emission tomography study
20. Cerebral glutamate, neuroleptic drugs and schizophrenia: Increase of cerebrospinal fluid glutamate levels and decrease of striate body glutamate level s following sulpiride treatment in rats
21. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
22. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in schizophrenia and depression
23. 3H]MK-801 binding sites in post-mortem brain regions of schizophrenic patients
24. Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients
25. Biological substrates of schizophrenia
26. Motor abnormalities in schizophrenia
27. Extrinsic connections of the basal ganglia
28. Normal cerebrospinal fluid and glutamate levels do not support the hypothesis of glutamatergic neuronal dysfunction
29. Schizophrenia, tardive dyskinesia and brain GABA
30. Effects of chronic administration of antipsychotic drugs on GABA and other amino acids in the mesolimbic area of rat brain
31. Gamma-aminobutyric acid deficiency in brain of schizophrenic patients
32. A hypothesis suggesting that there is a defect in the GABA system in schizophrenia
33. The neuropathology of schizophrenia: A progress report
34. PET studies on brain energy metabolism and dopamine receptors in schizophrenic patients and monkeys
35. Evidence of glutamatergic deficiency in schizophrenia
36. GABA uptake sites in Alzheimer's disease
37. Reduced GABA uptake sites in the temporal lobe in schizophrenia
38. Research Diagnostic Criteria: Rationale and reliability
39. Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects
40. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia
41. Neurotransmitters, receptors and neuropeptides in post-mortem brains of schizophrenic patients
42. Alterations anatomiques de la schizophrenie et d'autres psychoses dites fonctionelles